10-Q quarterly report · filed Nov 5, 2026

Prestige Consumer Healthcare Inc. (PBH) Q3 2026 10-Q Quarterly Report

Short answer

Prestige Consumer Healthcare Inc. (PBH) filed its Q3 2026 10-Q quarterly report on Nov 5, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $336M (up 22.7% year over year) with net income of $25M.

Q3 2026 key financials · XBRL

Revenue
$336M
+22.7% YoY · +26.6% QoQ
Net income
$25M
−40.1% YoY · −13.3% QoQ
Operating margin
24.0%
Gross margin
51.3%
EPS (diluted)
$0.53
−38.4% YoY · −13.1% QoQ

Source: XBRL data from the Prestige Consumer Healthcare Inc. (PBH) Q3 2026 10-Q on SEC EDGAR. USD.

Prestige Consumer Healthcare Inc. Q3 2026 10-Q analysis

AI summary of MD&A and risk factor updates

Management Discussion & Analysis

  • Quarterly revenue $336.3M, up 22.7% YoY from $274.1M, driven by OTC Wellness acquisition
  • Gross margin 51.3% vs 55.3% YoY, pressured by Pillar5 costs and acquisition inventory step-ups
  • Best category Wellness, Sleep & Other, $37.2M North America revenue, up 507.2% YoY
  • International OTC strongest segment, revenue $64.5M, up 48.7% YoY
  • Cash $46.5M, down $17.4M; operating cash flow $108.7M, down $27.8M YoY; acquisitions used $1.2B in investing cash

Risk Factors

  • No material changes to 10-K risk factors during the quarter
  • Quarterly results and revenues may fluctuate, limiting comparability across periods
  • Future results below analyst or investor expectations could depress securities prices
  • Unknown or currently immaterial risks could materially harm business, financial condition, or results

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Other Prestige Consumer Healthcare Inc. quarterly reports

Ask about this quarter

Compare quarters, check guidance or see what insiders and funds did around the report.